Gene study may explain why some breast cancers resist hormone therapy

This study looked at whether a specific gene mutation (HSD3B1) changes how well the hormone therapy letrozole works in postmenopausal women with early-stage, hormone-sensitive breast cancer. Researchers measured changes in tumor markers before and after treatment. The trial was ended early, but the goal was to learn why some cancers don't respond well to standard hormone therapy.